LEGN – legend biotech corporation - american depositary shares (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

LEGN

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/11

01:09 pm

legn

Rating for LEGN

Low Report

Rating for LEGN

Report

3/11

01:09 pm

legn

Rating for LEGN

Low Report

Rating for LEGN

Report

3/11

10:18 am

legn

Rating for LEGN

Low Report

Rating for LEGN

Report

3/11

10:18 am

legn

Rating for LEGN

Low Report

Rating for LEGN

Report

2/23

01:05 pm

legn

Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..

Medium Report

Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..

Report

2/4

09:26 am

legn

Rating for LEGN

Low Report

Rating for LEGN

Report

2/4

09:26 am

legn

Rating for LEGN

Low Report

Rating for LEGN

Report

1/20

03:13 pm

legn

Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..

Low Report

Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..

Report

1/20

12:47 pm

legn

Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $66.00 price target on the stock.

Report

Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $66.00 price target on the stock.

Report

1/20

12:47 pm

legn

Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $66.00 price target on the stock.

Report

Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $66.00 price target on the stock.

Report

1/20

12:32 pm

legn

Rating for LEGN

Low Report

Rating for LEGN

Report

1/20

12:32 pm

legn

Rating for LEGN

Low Report

Rating for LEGN

Report

1/7

10:38 am

legn

Rating for LEGN

Medium Report

Rating for LEGN

Report

1/7

10:38 am

legn

Rating for LEGN

Medium Report

Rating for LEGN

Report

1/7

09:00 am

legn

Legend Biotech (NASDAQ:LEGN) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $75.00 price target on the stock.

Medium Report

Legend Biotech (NASDAQ:LEGN) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $75.00 price target on the stock.

Report

1/7

08:33 am

legn

Legend Biotech initiated with an Outperform at Oppenheimer

Medium Report

Legend Biotech initiated with an Outperform at Oppenheimer

Report

1/7

08:33 am

legn

Legend Biotech initiated with an Outperform at Oppenheimer

Medium Report

Legend Biotech initiated with an Outperform at Oppenheimer

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.